GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Skystar Bio-Pharmaceutical Co (GREY:SKBI) » Definitions » Cyclically Adjusted Price-to-FCF

Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Cyclically Adjusted Price-to-FCF : (As of Jun. 20, 2024)


View and export this data going back to . Start your Free Trial

What is Skystar Bio-Pharmaceutical Co Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Skystar Bio-Pharmaceutical Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Skystar Bio-Pharmaceutical Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skystar Bio-Pharmaceutical Co Cyclically Adjusted Price-to-FCF Chart

Skystar Bio-Pharmaceutical Co Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Skystar Bio-Pharmaceutical Co Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Skystar Bio-Pharmaceutical Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - General subindustry, Skystar Bio-Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Skystar Bio-Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Skystar Bio-Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Skystar Bio-Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.



Skystar Bio-Pharmaceutical Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Skystar Bio-Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2014 is calculated as:

For example, Skystar Bio-Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2014 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Sep. 2014 (Change)*Current CPI (Sep. 2014)
=0.523/98.9000*98.9000
=0.523

Current CPI (Sep. 2014) = 98.9000.

Skystar Bio-Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
200412 20.337 74.488 27.002
200503 0.937 75.597 1.226
200506 -0.357 74.618 -0.473
200509 -0.471 75.290 -0.619
200512 -1.005 75.666 -1.314
200603 -0.156 76.340 -0.202
200606 -0.243 76.034 -0.316
200609 -0.090 76.413 -0.116
200612 0.110 77.793 0.140
200703 -0.199 78.884 -0.249
200706 -0.019 79.357 -0.024
200709 -0.489 81.276 -0.595
200712 0.629 82.911 0.750
200803 -0.302 85.485 -0.349
200806 -0.140 85.058 -0.163
200809 -0.086 85.057 -0.100
200812 1.073 83.956 1.264
200903 -0.049 84.457 -0.057
200906 -0.384 83.615 -0.454
200909 -0.362 84.369 -0.424
200912 0.142 85.386 0.164
201003 0.007 86.316 0.008
201006 -0.334 85.886 -0.385
201009 -0.496 87.267 -0.562
201012 1.315 89.289 1.457
201103 -0.973 91.154 -1.056
201106 -0.147 91.612 -0.159
201109 -0.305 92.711 -0.325
201112 0.140 92.885 0.149
201203 0.267 94.367 0.280
201206 -0.618 93.495 -0.654
201209 -0.538 94.482 -0.563
201212 1.679 95.237 1.744
201303 -1.285 96.372 -1.319
201306 -0.112 95.984 -0.115
201309 0.202 97.332 0.205
201312 0.472 97.624 0.478
201403 0.590 98.600 0.592
201406 0.690 98.200 0.695
201409 0.523 98.900 0.523

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Skystar Bio-Pharmaceutical Co  (GREY:SKBI) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Skystar Bio-Pharmaceutical Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Skystar Bio-Pharmaceutical Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Business Description

Traded in Other Exchanges
N/A
Address
No. 48 Keji Road, 4/F Building B, Chuangye Square, Gaoxin District, Xian, Shaanxi Province, CHN
Skystar Bio-Pharmaceutical Co is a holding company. Through its subsidiaries, it is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products in the People's Republic of China. The company provides individually packaged animal wellness and pharmaceutical products for retail sale. It generates revenue from the sales of four product lines namely, veterinary medications, micro-organism, feed additives, and vaccines. The firm develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine; topicals, supplements, probiotics; diagnostic kits and animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets.

Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Headlines

No Headlines